Diretrizes brasileiras para o manejo da agitação psicomotora: abordagem farmacológica 1 – tranquilização rápida

Autores

  • Leonardo Baldaçara Comissão de Emergências Psiquiátricas, Associação Brasileira de Psiquiatria (ABP), Rio de Janeiro, RJ. 2 Universidade Federal do Tocantins (UFT), Palmas, TO. 3 Secretaria de Estado de Saúde do Tocantins, Palmas, TO. 4 Coordenadoria de Saúde Mental, São Caetano do Sul, SP; Universidade de São Caetano do Sul, São Caetano do Sul, SP; Secretaria de Saúde do Município de Palmas, Palmas, TO. https://orcid.org/0000-0002-5201-8515
  • Flávia Ismael Pinto Comissão de Emergências Psiquiátricas
  • Verônica da Silveira Leite Comissão de Emergências Psiquiátricas
  • Renata N.S. Figueiredo Comissão de Emergências Psiquiátricas
  • Lucas A. Pereira Comissão de Emergências Psiquiátricas https://orcid.org/0000-0002-6357-762X
  • Daniel Augusto Corrêa Vasques Comissão de Emergências Psiquiátricas
  • Elie Leal de Barros Calfat Comissão de Emergências Psiquiátricas
  • Alexandre Rizkalla Comissão de Emergências Psiquiátricas
  • Cintia A. M. Périco Comissão de Emergências Psiquiátricas https://orcid.org/0000-0002-2664-5101
  • Deisy Mendes Porto Comissão de Emergências Psiquiátricas https://orcid.org/0000-0001-9671-358X
  • Carlos E. K. Zacharias Comissão de Emergências Psiquiátricas
  • Roberto M. dos Santos Comissão de Emergências Psiquiátricas https://orcid.org/0000-0003-0829-5483
  • Vicente de P. Gomes Júnior Comissão de Emergências Psiquiátricas, Associação Brasileira de Psiquiatria (ABP), Rio de Janeiro, RJ; Associação Psiquiátrica do Piauí (APPI), Teresina, PI.
  • Quirino Cordeiro Secretaria de Cuidados e Prevenção às Drogas
  • Antônio Geraldo da Silva Diretoria Executiva da Associação Brasileira de Psiquiatria (ABP)
  • Chei Tung Teng Comissão de Emergências Psiquiátricas
  • Alexandre Paim Díaz Translational Psychiatry Program https://orcid.org/0000-0002-6591-6648

DOI:

https://doi.org/10.25118/2763-9037.2021.v11.11

Palavras-chave:

Agitação psicomotora, agressividade, agentes tranquilizantes, emergência, transtornos mentais

Resumo

Evidências apontam que o tratamento farmacológico da agitação psicomotora é indicado apenas após as abordagens não farmacológicas falharem. A causa da agitação, os efeitos colaterais das medicações e suas contraindicações devem direcionar a escolha da medicação. A via oral deve ser preferida para administração; a administração intravenosa deve ser evitada. Todos os indivíduos devem ser monitorados antes e após a administração da medicação. Número de registro da revisão sistemática:
CRD42017054440.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Wilson MP, MacDonald K, Vilke GM, Feifel D. A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation. J Emerg Med. 2012;43:790-7.

Baldacara L, Sanches M, Cordeiro DC, Jackoswski AP. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, iprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone. Braz J Psychiatry. 2011;33:30-9.

McAllister-Williams RH, Ferrier IN. Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry. 2002;180:485-9.

Wilson MP, Pepper D, Currier GW, Holloman GH Jr, Feifel D. The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup. West J Emerg Med. 2012;13:26-34.

Garriga M, Pacchiarotti I, Kasper S, Zeller SL, Allen MH, Vazquez G, et al. Assessment and management of agitation in psychiatry: expert consensus. World J Biol Psychiatry. 2016;17:86-128.

Zeller SL, Rhoades RW. Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clin Ther. 2010;32:403-25.

Mantovani C, Migon MN, Alheira FV, Del-Ben CM. [Management of the violent or agitated patient]. Braz J Psychiatry. 2010;32 Suppl 2:S96-103.

Richmond JS, Berlin JS, Fishkind AB, Holloman GH Jr, Zeller SL, Wilson MP, et al. Verbal De-escalation of the agitated patient: consensus statement of the american association for emergency psychiatry project BETA De-escalation Workgroup. West J Emerg Med. 2012;13:17-25.

Baldacara L, Ismael F, Leite V, Pereira LA, Dos Santos RM, Gomes Junior VP, et al. Brazilian guidelines for the management of psychomotor agitation. Part 1. Non-pharmacological approach. Braz J Psychiatry. 2019;41:153-67.

Stahl S. Essential psychopharmacology. 3 ed. New York: Cambridge University Press; 2008.

Ahmed U, Jones H, Adams CE. Chlorpromazine for psychosis induced aggression or agitation. Cochrane Database Syst Rev. 2010;(4):CD007445.

Suzuki H, Gen K, Takahashi Y. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia. Hum Psychopharmacol. 2014;29:83-8.

Isbister GK, Calver LA, Page CB, Stokes B, Bryant JL, Downes MA. Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study. Ann Emerg Med. 2010;56:392-401.e1.

Information NCfB. Phenothiazine [Internet]. 2018 [cited 2020 Dec 10]. https://pubchem.ncbi.nlm. nih.gov/compound/Phenothiazine

Man PL, Chen CH. Rapid tranqulization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine. Psychosomatics. 1973;14:59-63.

Walther S, Moggi F, Horn H, Moskvitin K, Abderhalden C, Maier N, et al. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine. J Clin Psychopharmacol. 2014;34:124-8.

Kinon BJ, Ahl J, Rotelli MD, McMullen E. Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia. Am J Emerg Med. 2004;22:181-6.

Chan HY, Ree SC, Su LW, Chen JJ, Chou SY, Chen CK, et al. A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior. J Clin Psychopharmacol. 2014;34:355-8.

Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, et al. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. J Psychiatr Pract. 2007;13:170-7.

Dorevitch A, Katz N, Zemishlany Z, Aizenberg D, Weizman A. Intramuscular flunitrazepam versus intramuscular haloperidol in the emergenctreatment of aggressive psychotic behavior. Am J Psychiatry. 1999;156:142-4.

Fang M, Chen H, Li LH, Wu R, Li Y, Liu L, et al. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia. Int Clin Psychopharmacol. 2012;27:107-13.

Gillies D, Sampson S, Beck A, Rathbone J. Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst Rev. 2013;(4):CD003079.

Huf G, Alexander J, Gandhi P, Allen MH. Haloperidol plus promethazine for psychosisinduced aggression. Cochrane Database Syst Rev. 2016;11:CD005146.

Lim HK, Kim JJ, Pae CU, Lee CU, Lee C, Paik IH. Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study. Neuropsychobiology. 2010;62:81-6.

MacDonald K, Wilson M, Minassian A, Vilke GM, Becker O, Tallian K, et al. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation. J Clin Psychopharmacol. 2012;32:317-22.

MacDonald K, Wilson MP, Minassian A, Vilke GM, Perez R, Cobb P, et al. A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drugand alcohol-using patients. Gen Hosp Psychiatry. 2010;32:443-5.

Nobay F, Simon BC, Levitt MA, Dresden GM. A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients. Acad Emerg Med. 2004;11:744-9.

Preval H, Klotz SG, Southard R, Francis A. Rapidacting IM ziprasidone in a psychiatric emergency service: a naturalistic study. Gen Hosp Psychiatry. 2005;27:140-4.

Resnick M, Burton BT. Droperidol vs. haloperidol in the initial management of acutely agitated patients. J Clin Psychiatry. 1984;45:298-9.

Tran-Johnson TK, Sack DA, Marcus RN, Auby P, McQuade RD, Oren DA. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebocontrolled trial. J Clin Psychiatry. 2007;68:111-9.

Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, et al. Double-blind, placebocontrolled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry. 2001;158:1149-51.

Zhang H, Wang G, Zhao J, Xie S, Xu X, Shi J, et al. Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia. J Clin Psychopharmacol. 2013;33:178-85.

Asadollahi S, Heidari K, Hatamabadi H, Vafaee R, Yunesian S, Azadbakht A, et al. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, doubleblind, parallel-group trial. Int Clin Psychopharmacol. 2015;30:142-50.

Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, et al. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry. 2002;59:441-8.

Huf G, Coutinho ES, Adams CE, TREC Collaborative Group. Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ. 2007;335:869.

Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J. Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry. 2004;185:63-9.

Mantovani C, Labate CM, Sponholz A Jr, de Azevedo Marques JM, Guapo VG, de Simone Brito dos Santos ME, et al. Are low doses of antipsychotics effective in the management of psychomotor agitation? A randomized, ratedblind trial of 4 intramuscular interventions. J Clin Psychopharmacol. 2013;33:306-12.

Raveendran NS, Tharyan P, Alexander J, Adams CE, Group TREC-India II Collaborative Group. Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ. 2007;335:865.

TREC Collaborative Group. Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. BMJ. 2003;327:708-13.

Bieniek SA, Ownby RL, Penalver A, Dominguez RA. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy. 1998;18:57-62.

Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud RA, et al. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry. 2004;65:386-94.

Asadollahi S, Heidari K, Hatamabadi H, Vafaee R, Yunesian S, Azadbakht A, et al. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, doubleblind, parallel-group trial. Int Clin Psychopharmacol. 2015;30:142-50.

Chan EW, Taylor DM, Knott JC, Phillips GA, Castle DJ, Kong DC. Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Ann Emerg Med. 2013;61:72-81.

Martel M, Sterzinger A, Miner J, Clinton J, Biros M. Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam. Acad Emerg Med. 2005;12:1167-72.

Knott JC, Taylor DM, Castle DJ. Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. Ann Emerg Med. 2006;47:61-7.

Richards JR, Derlet RW, Duncan DR. Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol. J Emerg Med. 1998;16:567-73.

Rosen CL, Ratliff AF, Wolfe RE, Branney SW, Roe EJ, Pons PT. The efficacy of intravenous droperidol in the prehospital setting. J Emerg Med. 1997;15:13-7.

Taylor DM, Yap CY, Knott JC, Taylor SE, Phillips GA, Karro J, et al. Midazolam-droperidol, droperidol, or olanzapine for acute agitation: a randomized clinical trial. Ann Emerg Med. 2017;69:318-26.e1.

Yap CY, Taylor DM, Knott JC, Taylor SE, Phillips GA, Karro J, et al. Intravenous midazolamdroperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial. Addiction. 2017;112:1262-9.

Allen MH, Feifel D, Lesem MD, Zimbroff DL, Ross R, Munzar P, et al. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, doubleblind, placebo-controlled trial. J Clin Psychiatry. 2011;72:1313-21.

Kwentus J, Riesenberg RA, Marandi M, Manning RA, Allen MH, Fishman RS, et al. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebocontrolled clinical trial with inhaled loxapine. Bipolar Disord. 2012;14:31-40.

Stahl SM. Stahl SM. Stahl’s essential psychopharmacology. 3 ed. New York: Cambridge University Press; 2008.

Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, et al. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology (Berl). 2006;188:281-92.

De Filippis S, Cuomo I, Lionetto L, Janiri D, Simmaco M, Caloro M, et al. Intramuscular aripiprazole in the acute management of psychomotor agitation. Pharmacotherapy. 2013;33:603-14.55. Currier GW, Simpson GM. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry. 2001;62:153-7.

Veser FH, Veser BD, McMullan JT, Zealberg J, Currier GW. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial. J Psychiatr Pract. 2006;12:103-8.

Agid O, Kapur S, Warrington L, Loebel A, Siu C. Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders. Schizophr Res. 2008;102:241-8.

Gault TI, Gray SM, Vilke GM, Wilson MP. Are oral medications effective in the management of acute agitation? J Emerg Med. 2012;43:854-9.

Hsu WY, Huang SS, Lee BS, Chiu NY. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan. J Clin Psychopharmacol. 2010;30:230-4.

Hatta K, Kawabata T, Yoshida K, Hamakawa H, Wakejima T, Furuta K, et al. Olanzapine orally disintegrating tablet vs. risperidone oral solution in the treatment of acutely agitated psychotic patients. Gen Hosp Psychiatry. 2008;30:367-71.

Normann C, Schmauss M, Bakri N, Gerwe M, Schreiner A. Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets. Pharmacopsychiatry. 2006;39:209-12.

Zimbroff DL, Marcus RN, Manos G, Stock E, McQuade RD, Auby P, et al. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. J Clin Psychopharmacol. 2007;27:171-6.

Baker RW, Kinon BJ, Maguire GA, Liu H, Hill AL. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol. 2003;23:342-8.

Escobar R, San L, Perez V, Olivares JM, Polavieja P, Lopez-Carrero C, et al. [Effectiveness results of olanzapine in acute psychotic patients with agitation in the emergency room setting: results from NATURA study]. Actas Esp Psiquiatr. 2008;36:151-7.

Katagiri H, Fujikoshi S, Suzuki T, Fujita K, Sugiyama N, Takahashi M, et al. A randomized, doubleblind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation. BMC Psychiatry. 2013;13:20.

Castle DJ, Udristoiu T, Kim CY, Sarosi A, Pidrman V, Omar AN, et al. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation. World J Biol Psychiatry. 2009;10:43-53.

Perrin E, Anand E, Dyachkova Y, Wagner T, Frediani S, Ballerini A, et al. A prospective, observational study of the safety and effectiveness of intramuscular psychotropic treatment in acutely agitated patients with schizophrenia and bipolar mania. Eur Psychiatry. 2012;27:234-9.

Lesem MD, Tran-Johnson TK, Riesenberg RA, Feifel D, Allen MH, Fishman R, et al. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br J Psychiatry. 2011;198:51-8.

Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology (Berl). 2001;155:128-34.

Pratts M, Citrome L, Grant W, Leso L, Opler LA. A single-dose, randomized, double-blind, placebocontrolled trial of sublingual asenapine for acute agitation. Acta Psychiatr Scand. 2014; 130:61-8.

Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13:214-23.

Chouinard G, Annable L, Turnier L, Holobow N, Szkrumelak N. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. Can J Psychiatry. 1993;38 Suppl 4:S114-21.

Downloads

Publicado

2021-03-31

Como Citar

1.
Baldaçara L, Pinto FI, Leite V da S, Figueiredo RN, Pereira LA, Vasques DAC, Calfat EL de B, Rizkalla A, Périco CAM, Porto DM, Zacharias CEK, Santos RM dos, Gomes Júnior V de P, Cordeiro Q, Silva AG da, Teng CT, Díaz AP. Diretrizes brasileiras para o manejo da agitação psicomotora: abordagem farmacológica 1 – tranquilização rápida. Debates em Psiquiatria [Internet]. 31º de março de 2021 [citado 27º de setembro de 2022];11(1):28-35. Disponível em: https://revistardp.org.br/revista/article/view/11

Artigos Semelhantes

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.

Artigos mais lidos do(s) mesmo(s) autor(es)

<< < 3 4 5 6 7 8 9 > >>